نتایج جستجو برای: cyp2c9 and vkorc1 polymorphisms

تعداد نتایج: 16835218  

Journal: :Gastroenterology 2007
Alberto Pilotto Davide Seripa Marilisa Franceschi Carlo Scarcelli Donatella Colaizzo Elvira Grandone Valeria Niro Angelo Andriulli Gioacchino Leandro Francesco Di Mario Bruno Dallapiccola

BACKGROUND AND AIMS Several nonsteroidal anti-inflammatory drugs (NSAIDs) are metabolized by the cytochrome P450 2C9 (CYP2C9). Two common variants of the CYP2C9 gene (CYP2C9*2 and *3) were reported to significantly affect the activity of the CYP2C9 enzyme. The aim of this study was to evaluate the impact of CYP2C9 polymorphisms on the risk of gastroduodenal bleeding in acute NSAID users. METH...

Journal: :Pharmacogenomics 2012
Niclas Eriksson Mia Wadelius

Prediction models are the key to individualized drug therapy. Warfarin is a typical example of where pharmacogenetics could help the individual patient by modeling the dose, based on clinical factors and genetic variation in CYP2C9 and VKORC1. Clinical studies aiming to show whether pharmacogenetic warfarin dose predictions are superior to conventional initiation of warfarin are now underway. T...

2016
Nagendra Chaudhary Madhulika Kabra Sheffali Gulati Yogendra Kumar Gupta Ravindra Mohan Pandey Bal Dev Bhatia

BACKGROUND Phenytoin, mainly metabolized by cytochrome P450 enzyme system, has a narrow therapeutic index and may have adverse effects due to inter-individual variation in the dose requirement and genetic polymorphisms. This cross-sectional study was done to study the prevalence of cytochrome P450 CYP2C9 polymorphisms in Indian epileptic children and to see the effect of polymorphisms on serum ...

2013
Minoli A Perera Larisa H Cavallari Nita A Limdi Eric R Gamazon Anuar Konkashbaev Roxana Daneshjou Anna Pluzhnikov Dana C Crawford Jelai Wang Nianjun Liu Nicholas Tatonetti Stephane Bourgeois Harumi Takahashi Yukiko Bradford Benjamin M Burkley Robert J Desnick Jonathan L Halperin Sherief I Khalifa Taimour Y Langaee Steven A Lubitz Edith A Nutescu Matthew Oetjens Mohamed H Shahin Shitalben R Patel Hersh Sagreiya Matthew Tector Karen E Weck Mark J Rieder Stuart A Scott Alan HB Wu James K Burmester Mia Wadelius Panos Deloukas Michael J Wagner Taisei Mushiroda Michiaki Kubo Dan M Roden Nancy J Cox Russ B Altman Teri E Klein Yusuke Nakamura Julie A Johnson

BACKGROUND VKORC1 and CYP2C9 are important contributors to warfarin dose variability, but explain less variability for individuals of African descent than for those of European or Asian descent. We aimed to identify additional variants contributing to warfarin dose requirements in African Americans. METHODS We did a genome-wide association study of discovery and replication cohorts. Samples f...

2014
Ji Eun Lee Duck Hyun Ryu Ho Jung Jeong Jung Hoon Kim Ji Eun Jun June Soo Kim Soo Youn Lee

A 73-yr-old Korean man with permanent atrial fibrillation visited outpatient clinic with severely increased International Normalized Ratio (INR) values after taking a usual starting dosage of warfarin to prevent thromboembolism. We found out later from his blood tests that he had hyperthyroidism at the time of treatment initiation. His genetic analysis showed CYP2C9*1/*3 and VKORC1+1173TT genot...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید